Review summary
Teaching objective: Evaluate headaches with transient numbness and weakness of one side in a 51-year-old writer: distinguish focal seizures from transient ischemic attack and migraine aura, obtain MRI with gadolinium and an EEG, and give driving and seizure-safety advice at once. Confirm a left convexity meningioma over the motor cortex with vasogenic edema and focal epilepsy; start levetiracetam and monitor mood and irritability; use dexamethasone only for symptomatic edema and briefly; present observation, resection, and stereotactic radiosurgery by shared decision-making (EANO 2021 and NCCN); grade the tumor by the WHO CNS5 criteria after resection, decide on adjuvant treatment by grade and extent of resection, and set the surveillance MRI schedule. Throughout, take a grief history and screen for depression in a woman with many early losses, and protect her ability to write. The teaching note contrasts this with the supposed tumour of the left hemisphere on her death certificate and the hemiplegic migraine hypothesis.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| August 30, 1797 | Born in London. | CLM-0001 |
| September 10, 1797 | Her mother dies eleven days after the birth. | CLM-0002 |
| About 1811 to 1812 | A painful skin disease of one arm at about fourteen. | CLM-0010 |
| February 1815 | Her first child, born prematurely, dies after a few days. | CLM-0003 |
| January 1818 | Frankenstein published. | CLM-0004 |
| 1818 to June 1819 | Her daughter Clara and her son William die in Italy. | CLM-0005 |
| November 1819 | Her son Percy Florence is born. | CLM-0006 |
| June 1822 | Near-fatal hemorrhage after a miscarriage. | CLM-0007 |
| July 1822 | Her husband drowns in the Gulf of Spezia. | CLM-0008 |
| 1823 to 1844 | Novels, a revised Frankenstein, and travel writing. | CLM-0009 |
| 1839 | Recurrent headaches with transient right-sided paralysis and seizures begin. | CLM-0012 |
| June 1, 1840 | Writes in her journal of ill health and extreme depression. | CLM-0011 |
| 1846 to 1851 | Lives at 24 Chester Square; her son marries in 1848. | CLM-0013 |
| Late 1849 to 1851 | Worsening illness with impaired speech and loss of power in one side. | CLM-0014 |
| February 1, 1851 | Dies at Chester Square; the certificate records a supposed tumour of the left hemisphere. | CLM-0015, CLM-0016, CLM-0017 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Mary Wollstonecraft Godwin was born in London on August 30, 1797, the only child of the writer Mary Wollstonecraft and the philosopher William Godwin. | confirmed | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports Godwin W. Memoirs of the Author of A Vindication of the Rights of Woman (1798) supports |
| D | Her mother died in London on September 10, 1797, eleven days after the birth, of puerperal fever; her father wrote that the placenta had been retained and had to be removed by hand. The Bodleian timeline and a reference biography say ten days; the dates in her father's memoir (birth August 30, death September 10) give eleven. |
confirmed | Godwin W. Memoirs of the Author of A Vindication of the Rights of Woman (1798) supports Wollstonecraft, Mary 1759–1797. International Encyclopedia of the Social Sciences supports Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) context |
| D | Her first child, a daughter born prematurely in February 1815, died after a few days. No health facts about the child are used in this record. |
confirmed | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports |
| D | She began the tale that became Frankenstein in Switzerland in the summer of 1816, and Frankenstein; or, The Modern Prometheus was published anonymously in January 1818, when she was 20. | confirmed | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports |
| D | Her daughter Clara died in Italy in 1818, at about one year, and her son William died in Italy in June 1819, at three; she then had no living children. No health facts about the children are used in this record. |
confirmed | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports |
| D | Her son Percy Florence, born in November 1819, was the only one of her four children to survive childhood. | confirmed | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports |
| D | In June 1822 she nearly died of hemorrhage after a miscarriage about three months into a pregnancy; her husband stopped the bleeding by placing her in ice baths. | confirmed | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports |
| D | In July 1822 her husband, the poet Percy Bysshe Shelley, drowned while sailing in the Gulf of Spezia, leaving her a widow before she was 25, with a son of two; she decided to earn her living by her writing and by publishing his. | confirmed | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports |
| D | She published the novels Valperga (1823) and The Last Man (1826), a revised Frankenstein (1831), and Rambles in Germany and Italy (1844). | confirmed | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports |
| D | At about fourteen she had a very painful skin condition of one entire arm, treated with poultices; at times she could not move the arm and wore it in a sling. It has been interpreted as eczema, psoriasis, or chickenpox. Her biographer Fiona Sampson as quoted in a 2022 paper; the diagnosis is uncertain. |
confirmed | Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 supports |
| D | In her journal in June 1840 she wrote that she had been long oppressed by care, disappointment, and ill health, and that lately ill health and extreme depression had marred what little she could do for others. Her own words; no diagnosis was made in her lifetime. |
confirmed | Marshall J (Mrs). The Life and Letters of Mary Wollstonecraft Shelley, Volume 2. London: Richard Bentley; 1889 supports |
| D | From 1839 she had recurrent severe headaches of varying severity, site, and duration, with dizziness, pain in the legs, right hand, and right eye, brief episodes of partial paralysis of the right leg and hand, tremors, and convulsive seizures. Her physicians called the illness psychosomatic in 1842, a functional derangement of the nerves or brain in 1845, and neuralgia of the heart in 1846. Her documented symptoms as summarized in a 2018 Lancet Neurology letter; the diagnoses are those of her time. |
confirmed | Charlier P, Appenzeller O, Deo S, Perciaccante A, Bianucci R. Hemiplegic migraine and stroke in Mary Shelley. Lancet Neurol 2018;17(4):305. PMID 29553379 supports Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 supports Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 supports |
| D | From 1846 to 1851 she lived at 24 Chester Square, Belgravia, London, and spent time at Field Place in Sussex, the home of her son and his wife after their marriage in 1848. An 1890 biography says the Chester Square house was given up in 1848 for one in Warwick Square; the 1889 biography and the blue plaque place her at Chester Square until her death. |
confirmed | Mary Shelley (1797-1851): blue plaque, 24 Chester Square supports Rossetti LM. Mrs. Shelley (Eminent Women Series). London: W. H. Allen; 1890. Chapter 17 supports Marshall J (Mrs). The Life and Letters of Mary Wollstonecraft Shelley, Volume 2. London: Richard Bentley; 1889 supports |
| D | Her symptoms worsened from late 1849, with impaired speech and difficulty moving; her nervous ailments increased until she lost power in one side, and she could not be moved from her house in Chester Square. Later than the synthetic index visit; linked only to a later timeline event. |
confirmed | Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 supports Marshall J (Mrs). The Life and Letters of Mary Wollstonecraft Shelley, Volume 2. London: Richard Bentley; 1889 supports |
| D | She died at Chester Square, London, on February 1, 1851, aged 53. Her death certificate recorded "Disease of the Brain Supposed Tumour in left hemisphere, of long standing." No autopsy was done. The certificate's wording is documented; the tumour was supposed, not proven (see CLM-0016 and CLM-0017). The 1889 and 1890 biographies give February 21. |
confirmed | Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 supports Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 supports |
| R | Her death has long been attributed to a brain tumour: the Bodleian Libraries describe a long illness possibly caused by a brain tumour, and a reference biography says she succumbed to one. A retrospective interpretation resting on the death certificate's supposed tumour; no tissue or imaging exists. |
possible | Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 context |
| R | A 2018 Lancet Neurology letter and a 2022 paper argue instead that twelve years of recurrent episodes make a tumour unlikely and that she had hemiplegic migraine with recurrent and finally fatal stroke; the 2022 paper links these to the skin disease of her adolescence. A competing retrospective interpretation. |
disputed | Charlier P, Appenzeller O, Deo S, Perciaccante A, Bianucci R. Hemiplegic migraine and stroke in Mary Shelley. Lancet Neurol 2018;17(4):305. PMID 29553379 supports Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 supports Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Headaches, worse in the morning, for about two years, with episodes over six months of tingling and weakness of the right hand and leg lasting a few minutes, one with twitching of the right fingers and one with difficulty finding words; mild right-hand weakness on examination; cause not yet established; urgent MRI and EEG booked | resolved | confirmed | active | CLM-0012 |
| S | Meningioma of the left frontoparietal convexity over the hand area of the motor cortex, 3.1 x 2.7 x 2.6 cm, with moderate vasogenic edema; resected (Simpson grade I); meningothelial meningioma, CNS WHO grade 1; synthetic modern counterpart of the supposed tumour of the left hemisphere on her death certificate | active | confirmed | both_with_link | CLM-0012, CLM-0015, CLM-0016, CLM-0017 |
| S | Focal epilepsy due to the left convexity meningioma: focal aware sensory and motor seizures of the right hand and arm, one with speech arrest; EEG with left central sharp waves; on levetiracetam | active | confirmed | both_with_link | CLM-0012, CLM-0017 |
| S | Acute viral gastroenteritis for two days, with vomiting of one levetiracetam dose, mild dehydration, and no seizure; resolved in four days | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | http://loinc.org · 44261-6 |
| S | 2026-03-03 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | http://loinc.org · 70274-6 |
| S | 2026-03-03 | Total score [MoCA] | 27 | http://loinc.org · 72172-0 |
| S | 2026-03-03 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-03-03 | Potassium [Moles/volume] in Serum or Plasma | 4.1 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-03-03 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 2026-03-03 | Urea nitrogen [Mass/volume] in Serum or Plasma | 13 mg/dL Reference 6-21 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-03-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.74 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-03-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 98 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-03-03 | Glucose [Mass/volume] in Serum or Plasma | 91 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-03-03 | Calcium [Mass/volume] in Serum or Plasma | 9.3 mg/dL Reference 8.6-10.3 mg/dL |
http://loinc.org · 17861-6 |
| S | 2026-03-03 | Hemoglobin [Mass/volume] in Blood | 12.8 g/dL Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-03-03 | Leukocytes [#/volume] in Blood by Automated count | 6.1 10*3/uL Reference 3.4-9.6 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-03-03 | Platelets [#/volume] in Blood by Automated count | 252 10*3/uL Reference 157-371 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-03-03 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 mIU/L Reference 0.4-4 mIU/L |
http://loinc.org · 3016-3 |
| S | 2026-03-17 | INR in Platelet poor plasma by Coagulation assay | 1 Reference 0.8-1.2 |
http://loinc.org · 6301-6 |
| S | 2026-03-17 | Hemoglobin [Mass/volume] in Blood | 12.7 g/dL Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-03-17 | Platelets [#/volume] in Blood by Automated count | 248 10*3/uL Reference 157-371 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-03-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | http://loinc.org · 44261-6 |
| S | 2026-04-28 | Glucose [Mass/volume] in Serum or Plasma | 96 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-04-28 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-04-28 | Hemoglobin [Mass/volume] in Blood | 12.1 g/dL Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-04-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | http://loinc.org · 44261-6 |
| S | 2026-07-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | http://loinc.org · 44261-6 |
| S | 2026-07-07 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | http://loinc.org · 70274-6 |
| S | 2026-09-29 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | http://loinc.org · 44261-6 |
| S | 2026-09-29 | Total score [MoCA] | 29 | http://loinc.org · 72172-0 |
| S | 2026-09-29 | Creatinine [Mass/volume] in Serum or Plasma | 0.76 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-09-29 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 95 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-08-11 | Sodium [Moles/volume] in Serum or Plasma | 136 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-08-11 | Potassium [Moles/volume] in Serum or Plasma | 3.6 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-08-11 | Urea nitrogen [Mass/volume] in Serum or Plasma | 22 mg/dL (high) Reference 6-21 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-08-11 | Creatinine [Mass/volume] in Serum or Plasma | 0.91 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-08-11 | Glucose [Mass/volume] in Serum or Plasma | 88 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-10-20 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2026-10-20 | Total score [AUDIT-C] | 1 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-03-03 | Body height | 160 cm | 8302-2 | S |
| 2026-03-03 | Body weight | 57.2 kg | 29463-7 | S |
| 2026-03-03 | Body mass index (BMI) [Ratio] | 22.3 kg/m2 | 39156-5 | S |
| 2026-03-03 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 2026-03-03 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-03-03 | Heart rate | 76 /min | 8867-4 | S |
| 2026-03-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-03 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-03-17 | Body height | 160 cm | 8302-2 | S |
| 2026-03-17 | Body weight | 57 kg | 29463-7 | S |
| 2026-03-17 | Body mass index (BMI) [Ratio] | 22.3 kg/m2 | 39156-5 | S |
| 2026-03-17 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-03-17 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-03-17 | Heart rate | 80 /min | 8867-4 | S |
| 2026-03-17 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-17 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-03-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-04-28 | Body height | 160 cm | 8302-2 | S |
| 2026-04-28 | Body weight | 58.1 kg | 29463-7 | S |
| 2026-04-28 | Body mass index (BMI) [Ratio] | 22.7 kg/m2 | 39156-5 | S |
| 2026-04-28 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 2026-04-28 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-04-28 | Heart rate | 74 /min | 8867-4 | S |
| 2026-04-28 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-04-28 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-07-07 | Body height | 160 cm | 8302-2 | S |
| 2026-07-07 | Body weight | 57.6 kg | 29463-7 | S |
| 2026-07-07 | Body mass index (BMI) [Ratio] | 22.5 kg/m2 | 39156-5 | S |
| 2026-07-07 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-07-07 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-07-07 | Heart rate | 70 /min | 8867-4 | S |
| 2026-07-07 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-07-07 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-09-29 | Body height | 160 cm | 8302-2 | S |
| 2026-09-29 | Body weight | 57.4 kg | 29463-7 | S |
| 2026-09-29 | Body mass index (BMI) [Ratio] | 22.4 kg/m2 | 39156-5 | S |
| 2026-09-29 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-09-29 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-09-29 | Heart rate | 68 /min | 8867-4 | S |
| 2026-09-29 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-09-29 | Body temperature | 36.5 Cel | 8310-5 | S |
| 2026-09-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-08-11 | Body height | 160 cm | 8302-2 | S |
| 2026-08-11 | Body weight | 56.3 kg | 29463-7 | S |
| 2026-08-11 | Body mass index (BMI) [Ratio] | 22 kg/m2 | 39156-5 | S |
| 2026-08-11 | Systolic blood pressure | 108 mm[Hg] | 8480-6 | S |
| 2026-08-11 | Diastolic blood pressure | 70 mm[Hg] | 8462-4 | S |
| 2026-08-11 | Heart rate | 96 /min | 8867-4 | S |
| 2026-08-11 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-08-11 | Body temperature | 37.6 Cel | 8310-5 | S |
| 2026-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-10-20 | Body height | 160 cm | 8302-2 | S |
| 2026-10-20 | Body weight | 57.5 kg | 29463-7 | S |
| 2026-10-20 | Body mass index (BMI) [Ratio] | 22.5 kg/m2 | 39156-5 | S |
| 2026-10-20 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 2026-10-20 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-10-20 | Heart rate | 70 /min | 8867-4 | S |
| 2026-10-20 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-10-20 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: novelist, travel writer, and editor of her late husband's poems; working on a new novel and a travel book; writes by hand each morning
- S Bereavement history: her mother died days after her birth; widowed in her twenties; three of her four children died in infancy or early childhood; a near-fatal miscarriage; one adult son, married
- S Lives alone in a London house; spends some weeks at her son's country home; drives occasionally
- S Never smoker; a glass of wine with dinner a few times a week; walks most days; no other substance use
- S Supports: a few close friends, her publisher, and her son and daughter-in-law; finds meaning in her work
- S Reproductive history: four live births and one miscarriage; menopause at 50; no hormone therapy
Functional status
- S Independent in all activities of daily living; writing slowed because her right hand tires and twice the pen dropped during an episode
Mental status
- S Alert, articulate, and composed; mood "tired and frightened"; affect appropriate; no psychotic features; no thoughts of suicide; speaks of old griefs as long carried rather than new; MoCA 27
Allergies and medications
Allergies
- S No known allergy
Medications
- S Levetiracetam 500 mg oral tablet, one tablet by mouth twice a day
- S Dexamethasone 4 mg oral tablet, one tablet twice a day for three days before surgery, then tapered and stopped over ten days after surgery
- S Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for headache or wound pain, no more than 3000 mg a day
- S Ondansetron 4 mg orally disintegrating tablet, one tablet on the tongue every 8 hours as needed for vomiting, for up to two days
Procedures and immunizations
Procedures
- S Resting 12-lead electrocardiogram: sinus rhythm 74/min, normal intervals
- S MRI of the brain with and without gadolinium, with diffusion imaging and MR angiography of the head and neck: a 3.1 x 2.7 x 2.6 cm extra-axial, dural-based, uniformly enhancing mass on the left frontoparietal convexity over the hand area of the precentral gyrus, with a dural tail and a cerebrospinal fluid cleft; moderate vasogenic edema extending 2.5 cm into the white matter; 2 mm midline shift; no infarct, no other lesion; arteries normal. Appearance typical of a meningioma
- S Routine EEG with sleep deprivation: intermittent focal slowing and sharp waves over the left central region (C3); no seizure recorded
- S Left frontoparietal craniotomy with total excision of the convexity meningioma, its dural attachment, and a margin of dura (Simpson grade I), with neuronavigation and motor mapping; dural graft. Pathology: meningothelial meningioma, CNS WHO grade 1 (1 mitosis per 10 high-power fields, no brain invasion, no atypical features; Ki-67 3 percent; no TERT promoter mutation or CDKN2A/B homozygous deletion)
- S MRI of the brain with gadolinium the day after surgery: gross total resection with no residual enhancement; expected postoperative changes; edema smaller
- S MRI of the brain with gadolinium three months after surgery: no residual or recurrent tumor; edema resolved; small area of gliosis under the craniotomy
Immunizations
- S 2025-10-21: Influenza vaccine, 2025-2026 season
- S 2020-06-15: Tdap vaccine
- S 2026-10-20: Influenza vaccine, 2026-2027 season
- S 2026-10-20: Recombinant zoster vaccine, dose 1 of 2
- S 2026-10-20: Pneumococcal conjugate vaccine PCV20
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D About 1811 to 1812: Painful skin disease of one whole arm at about fourteen, treated with poultices and a sling; diagnosis uncertain (CLM-0010)
- D 1815 to 1819: Four pregnancies carried to birth, the first ending in a premature delivery (CLM-0003, CLM-0006)
- D June 1822: Miscarriage at about three months with near-fatal hemorrhage, treated with ice baths (CLM-0007)
- D From 1839: Recurrent severe headaches with dizziness, pain in the right hand and eye, transient partial paralysis of the right leg and hand, tremors, and convulsive seizures; called psychosomatic, a derangement of the nerves, and neuralgia by her physicians (CLM-0012)
- D June 1, 1840: Ill health and extreme depression recorded in her journal (CLM-0011)
Family history
- D mother: Died of puerperal fever eleven days after giving birth to her, after a retained placenta
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| A diagnosis within two weeks, explained in plain words with the images and reports | 2026-03-17 | completed | MRI and EEG within a week; diagnosis explained at two weeks with the images |
| No further seizures | 2027-04-07 | active | No seizure since the craniotomy |
| Full use of the right hand and return to writing every morning | 2026-09-29 | completed | Grip equal on both sides by three months; writing every morning |
| Decide on treatment herself after hearing the options, benefits, and harms | 2026-03-17 | completed | Chose resection after observation and radiosurgery were explained |
| Mood and grief supported: PHQ-9 below 5 and a counselor available | 2026-09-29 | completed | PHQ-9 4 at six months; completed eight sessions with the neuro-oncology counselor |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Urgent MRI of the brain with and without gadolinium, with diffusion imaging and MR angiography of the head and neck, within three days; EEG within a week; ECG, blood count, metabolic panel, calcium, and TSH today; headache and episode diary | completed | GL-AAN-SEIZ-2015, GL-NCCN-CNS-2025 |
| Safety now: no driving until the cause is known and her seizures are controlled for the period her state requires; showers rather than baths, no swimming alone, and no work at heights; seizure first aid explained; come at once for a longer episode, weakness that does not recover, or a severe sudden headache | completed | GL-AAN-SEIZ-2015 |
| Neurosurgery consultation if the MRI shows a structural lesion, to explain the options and their risks to her and plan treatment with her | completed | GL-NCCN-CNS-2025 |
| Grief and mood: a grief history, PHQ-9 and GAD-7 at each visit, and the neuro-oncology counselor offered; no assumption that her symptoms are "nerves" | completed | GL-USPSTF-DEP-2023, GL-CMID-2026 |
| Protect her writing: occupational therapy assessment of hand function if weakness persists, and voice dictation as a backup | completed | GL-NCCN-CNS-2025 |
| Levetiracetam 500 mg twice a day for focal epilepsy due to the meningioma; seizure diary; ask about irritability and low mood at each visit; continue for at least a year after surgery, then decide with her whether to taper after an EEG | completed | GL-AAN-SEIZ-2015, GL-ILAE-EPI-2014, GL-SNO-ASM-2021 |
| Shared decision: resection by craniotomy aiming at Simpson grade I, her choice after observation (not advised for a symptomatic tumor with edema and seizures) and stereotactic radiosurgery (less suitable at 3.1 cm with edema next to the motor cortex) were explained; dexamethasone 4 mg twice a day from three days before surgery, tapered and stopped after it; MRI within 48 hours after surgery | completed | GL-EANO-MEN-2021, GL-NCCN-CNS-2025 |
| After resection of a CNS WHO grade 1 meningioma (Simpson grade I): no radiation; MRI at three months and then yearly for five years, then every two years; no progestin-containing hormone therapy without discussion | completed | GL-EANO-MEN-2021, GL-NCCN-CNS-2025 |
Planned encounters
- 2026-03-03 — Primary care visit for headaches with episodes of numbness and weakness of the right hand and leg (ENC-001)
- 2026-03-17 — MRI and EEG results, start of levetiracetam, and neurosurgical consultation (ENC-002)
- 2026-04-28 — Review three weeks after craniotomy, with the pathology (ENC-003)
- 2026-07-07 — Three-month MRI review after resection (ENC-004)
- 2026-08-11 — Same-day sick visit for vomiting and diarrhea on levetiracetam (ENC-006, unscheduled)
- 2026-09-29 — Six-month review after resection: seizures, mood, and writing (ENC-005)
- 2026-10-20 — Adult preventive visit (ENC-007)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Sick Visit
- Progress note 06 — Focused Visit (Care-plan review)
- Progress note 07 — Preventive Visit
- Neurosurgery referral
- Neurosurgery consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Sick Visit (XML)
- Progress note 06 — Focused Visit (Care-plan review) (XML)
- Progress note 07 — Preventive Visit (XML)
- Neurosurgery referral (XML)
- Neurosurgery consultation (XML)
Sources
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the differential of transient focal episodes, the timing of levetiracetam, the short dexamethasone course, the choice of resection over radiosurgery, the WHO CNS5 grading and the decision against radiation, the surveillance schedule, the driving advice, and the recorded deviations. |
| provenance review | not_started | Bodleian Libraries timeline, a Gale reference biography, her father's memoir and a Gale entry for her mother, two peer-reviewed papers (2018 abstract and 2022 full text), a medical-humanities essay, the 1889 and 1890 biographies, and the English Heritage plaque. Her symptoms and the death certificate are D; a brain tumour, and the competing hemiplegic migraine and stroke hypothesis, are R. A meningioma was not found proposed in any fetched source. |
| safe messaging review | not_started | No behavioral-health diagnosis; mild depressive symptoms and grief are screened and supported, with PHQ-9 never above 9 and item 9 always 0. Her many documented bereavements are summarized without detail, and no statement or decision is attributed to her son or any other relative. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.